United States: CDC Experts Recommend People Over 65 Receive Third Dose Of Pfizer Coronavirus Vaccine

The COVID-19 vaccination campaign in United States is about to enter a new and important phase: Government advisers recommended Thursday to apply booster doses of Pfizer vaccine to millions of Americans. This despite the fear of some experts that additional injections they will do little to stop the pandemic.

The Centers for Disease Control and Prevention Advisory Group (CDC) additional doses recommended for people 65 years or older, the inhabitants of nursing homes and people aged 50 to 64 with underlying health conditions. The additional dose would be administered after at least six month since they received their last injection of Pfizer.

Deciding who else might be eligible for a recall was much more complicated. Although there is little evidence that young people are at risk of reduced immunity, the panel offered the option of a booster to people aged 18 to 49 with chronic conditions who want a new dose.

Recommendations from the Advisory Committee on Immunization Practices came a day after the Food and Drug Administration (FDA) issue an emergency permit for persons 65 years of age or over toAs well as those whose jobs put them at risk of infection, who received the vaccine from Pfizer Inc. and BioNTech SE have received boosters. An authorization had already been issued offering additional doses to people with weakened immune systems.

The FDA, the body that regulates drug marketing, cleared a third dose of Pfizer vaccine yesterday also for adults at risk for health or particularly exposed to covid-19.

This last group of people specially exposed consists of health workers, teachers, caregivers, supermarket workers, homeless and deprived of liberty, as detailed by the FDA.

“Today’s decision demonstrates that currently available science and data continue to guide the FDA’s decision making for covid-19 vaccines during this pandemic,” The agency’s director, Janet Woodcock, said in a statement.

He also said that as more information became available on “safety and efficiency ” vaccines, including third doses, the FDA will “assess” this information.

This FDA decision is being debated in United States on the need to administer a third dose to its entire population and throughout the world on whether to do so when other countries still do not have enough vaccines.

Authorization of the third dose for these groups of people It occurs a week after being recommended by an FDA advisory committee.

The recommendation was made in a second vote having previously rejected, with broad support, the project of a third dose for the majority of the population, considering that there is insufficient evidence to give a third dose to everyone.

This restricts the request of Pfizer, which had requested approval for people over 16 years of this reinforcement, six months after the second dose.

This recommendation is a wake-up call for the government of Joe biden, which had explicitly endorsed Pfizer’s proposal and started making plans to start giving this third dose to people over 16 with one eye around September 20.

In a statement, Pfizer CEO Albert Bourla said that “vaccine recalls have an important role to play in addressing the continuing threat of this disease” and called the FDA decision a “crucial step” in the fight against COVID-19.

Pfizer’s vaccine is the only vaccine fully approved for use by the FDA, since Pfizer’s vaccine Modern and Johnson & Johnson They only have emergency clearance.

(With information from EFE)

Read on: